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Sunday, February 3, 2013 17aother steep) in rat skinned cardiac myocytes, and (iii) troponin can be more
readily exchanged in permeabilized striated muscle cell preparations. To test
if PKA-mediated phosphorylation of cTnI is sufficient to mediate length
dependence of force we used skinned rat slow-twitch skeletal muscle fibers,
which exhibit shallow length-tension relationships that are unaltered by
PKA. A sarcomere length-tension relationship was measured during submaxi-
mal Ca2þ activation, then the fiber was incubated in a troponin (Tn) exchange
solution, which replaced ~80% of the endogenous slow-skeletal Tn with cTn.
After cTn incorporation the length-tension relationship remained shallow as
predicted since the purified cTnI lacks phosphate incorporation. Next, the fiber
was incubated in PKA, which caused the length-tension relationship to shift
from shallow to steep. In addition, exchange with cTn having cTnI serines
23/24 modified to aspartic acids to mimic phosphorylation steepened the
length-tension relationship. These results indicate that phosphorylation of
cTnI serines 23/24 is sufficient to control length dependence of force generation
in striated muscle.
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Background Recently, we observed reduced myofilament length-dependent
activation in cardiomyocytes from a patient harboring a homozygous mutation
(K280N) in the TNNT2 gene encoding cardiac troponin T (cTnT) compared to
non-failing donors. Protein kinase A (PKA)-mediated phosphorylation of car-
diac troponin I (cTnI) did not rescue impaired length-dependence. Moreover,
cTnI phosphorylation did not differ between TNNT2mut and donor myocardium.
In this study we present direct evidence that the K280N mutation in TNNT2
blunts length-dependent activation.
Methods Force measurements were performed in single permeabilized cardio-
myocytes isolated from the TNNT2mut heart at various [Ca
2þ] and sarcomere
lengths of 1.8 and 2.2 mm, with and without PKA-pretreatment. To investigate
if mutant cTnT underlies impaired length-dependent activation, the endoge-
nous mutant troponin complex was partially exchanged with recombinant
whole human wild-type troponin (Tnwt) complex. TNNT2mut sample was ex-
changed with 0.25, 0.5 and 1 mg/mL Tnwt complex, which in accordance
with previous studies from our group is predicted to yield ~40%, ~50% and
~70% of troponin exchange, respectively.
Results The length-dependent increase in myofilament Ca2þ-sensitivity
(DEC50) was not significantly different between TNNT2mut, TNNT2~40%,
TNNT2~50%, TNNT2~70%, (DEC50=0.3550.16, 0.2350.06, 0.0250.02 and
0.2250.06 mmol/L, respectively), but was significantly reduced compared to
donor (DEC50=0.7750.06 mmol/L). PKA-pretreatment did not restore
the reduced length-dependent activation of TNNT2mut and TNNT2~40%
(DEC50=0.2650.19 and 0.3250.15), but did recover the blunted length-
dependent activation of TNNT2~50% and TNNT2~70% (DEC50=0.7150.04 and
0.7950.14) to control values (DEC50=0.8250.09).
Conclusions Length-dependent activation of myofilaments is corrected to do-
nor values only when ~50% of mutant cTnT is replaced by wild-type troponin
and subsequent phosphorylation with PKA. Our data show that the TNNT2
mutation K280N underlies impaired length-dependent activation in a dose-
dependent manner.
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We previously reported that increased cellular 2-deoxy-ATP (dATP) augments
contraction, enhancing the rate and magnitude of both contraction and relaxa-
tion in intact cardiomyocytes, force production in skinned cardiac muscle, and
fractional shortening of the whole heart. To better understand the mechanism
by which dATP enhances cardiac function, we used molecular dynamics
(MD) simulations to study the pre- and post-powerstroke states of myosin
(PDB ID: 1VOM and 1MMA) bound to either Mg2þ.(d)ADP.Pi (pre-power-
stroke) or Mg2þ.(d)ADP (post-powerstroke) for 50ns. In both states, dATP
binding to myosin alters the conformation of the nucleotide binding pocketand the actin binding surface. In the pre-powerstroke state, myosin made fewer
contacts with dADP than with ADP and this structural change translated
to increased exposure of polar residues on the actin-binding surface of
myosin. Since the initial acto-myosin interaction is primarily electrostatic,
the affinity of myosin for actin may thus be enhanced with dADP.Pi. In
post-powerstroke simulations, dADP binding reduced the exposure of actin
binding residues on myosin somewhat. This may translate into improved
ability for myosin detachment from actin at the end of the powerstroke in
the presence of dADP vs. ADP. Furthermore, stopped-flow spectroscopy
demonstrated that myosin has 40-80% weaker binding affinity for dADP
than ADP, which may also contribute to faster myosin detachment. Together,
these data demonstrate that dADP binding to myosin significantly alters the
conformation of myosin, which may translate to faster cross-bridge cycling
due to both enhanced myosin binding in the pre-powerstroke state and faster
myosin detachment from actin in the post-powerstroke state. Ongoing studies
examining the effect of enhanced cross-bridge cycling with elevated dATP in
infarcted hearts suggest that dATP may reduce the loss of systolic function.
Supported by HL111197 (MR), WT085309 (MAG), GM50789 (VD) and
T32EB001650 (SGN).
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Proper contraction and relaxation of the heart depends on highly orchestrated
and rapid release and reuptake of Ca2þ from the sarcoplasmic reticulum
(SR). Normal SR Ca2þ reuptake in the rodent heart is accomplished predomi-
nately by the cardiac Ca-ATPase, SERCA2a, which in the failing heart exhibits
diminished activity and expression. We have utilized a mouse model of
inducible cardiac Ca2þ dysregulation, the Serca2fl/fl mouse, to investigate the
relationship between diminished SR Ca2þ flux and heart dysfunction. Condi-
tional deletion of Serca2 initiates the progressive loss of SERCA2 protein,
allowing us to examine in fine detail the relationship between titrated loss of
SR Ca2þ flux and heart dysfunction. By four weeks post-knockout, SERCA2
protein levels are below 5% of baseline and isolated 4-week KO cardiomyo-
cytes have greatly diminished contractility and Ca2þ handling. The in vivo phe-
notype at this time, however, is unexpectedly mild, and although all KO mice
succumb to congestive heart failure, they do so from 7-10 weeks after knock-
out. This disconnect between the mild in vivo phenotype and severe ex vivo
phenotype is intriguing and prompts the hypothesis that a systemic signaling
pathway, such as adrenergic signaling, is responsible for sustaining function
in KO animals. We found that in isolated Serca2 KO hearts, ß-adrenergic stim-
ulation elicits a robust inotropic and lusitropic response despite the near-
complete lack of SERCA2 protein. This finding will be discussed as it is at
odds with prevailing views of Ca2þ regulation of heart function.
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The naturally occurring, heterozygous Arg9-to-Cys (R9C) missense mutation
of phospholamban (PLB) triggers dilated cardiomyopathy, heart failure and
premature death in humans. However, the fundamental molecular mechanism
underlying the cardiotoxic role of PLBR9C in regulation of sarcoplasmic retic-
ulum (SR) Ca2þ-ATPase (SERCA) and cardiomyocyte Ca2þ handling is not
clear. The dynamic equilibrium between PLB monomer and pentamer plays
a critical role in SERCA regulation. We compared the effect of R9C and
pentamer-destabilizing transmembrane triple cysteine mutation (SSS) on PLB
pentameric assembly. We co-expressed Cer- or YFP-tagged PLBWT, PLBR9C,
PLBSSS, or PLBR9CþSSS in AAV-293 cells and measured intrapentameric Fluo-
rescence Resonance Energy Transfer (FRET). PLBR9C and PLBR9CþSSS ex-
hibited a significant increase in oligomerization as compared to PLBWT and
PLBSSS, which was further enhanced by application of 100mM H2O2. In addi-
tion, we investigated the stability of PLB pentamer in WT, R9C, SSS, or
R9CþSSS background by molecular dynamic simulation studies. Importantly,
co-expression of CFP-PLBR9C and YFP-PLBR9C in adult rabbit ventricular my-
ocytes exhibited a large and rapid increase in oligomerization over time after
exposure to 100mM H2O2 as compared to PLB
WT. To investigate the effect
18a Sunday, February 3, 2013of PLBR9C on SR Ca2þ kinetics, we recorded Ca2þ transients in electrically
paced adult cardiomyocytes overexpressing CFP-PLBR9C or CFP-PLBWT.
PLBR9C overexpressing cardiomyocytes exhibited faster SR Ca2þ uptake as
compared to PLBWT, and a blunted Ca2þ uptake/pacing frequency response.
We propose that R9C mutation in PLB increases the stability of the PLB pen-
tameric assembly by crosslinking of adjacent cysteine thiols via disulfide bonds,
and these effects are enhanced during oxidative stress. The resultant decrease in
availability of PLB monomeric species leads to decrease in inhibition of
SERCA, inability to respond to stress, and eventual heart failure.
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Background. Increased myofilament Ca2þ sensitivity has been associated with
cardiac arrhythmias in several cardiomyopathies. During the course of myocar-
dial infarction (MI), myofilament Ca2þ sensitivity is reduced during acute
ischemia but increases in the chronic stage. Thus, we aimed to compare the ar-
rhythmogenic patterns during an acute MI or after chronic MI in mice.
Methods. In theacute MI group, isolated hearts were investigated 15 min after
left anterior descending (LAD) coronary artery ligation. In the chronic MI
group, hearts were harvested 4 weeks after LAD ligation. To measure arrhyth-
mia susceptibility, isolated hearts from both groups underwent a ventricular
pacing challenge consisting of pacing trains of increasing frequency, followed
by a pause and an extra stimulus, in the presence or in the absence of the Ca2þ
sensitizer EMD 57033 (3 mM) or the Ca2þ de-sensitizer and contractile uncou-
pler Blebbistatin (3 mM).
Results. Acute MI caused frequent ventricular ectopyduring the steady-state
pacing, but not after a pause. Acute MI hearts became susceptible to post-
pause ectopy only after Ca2þ sensitization with EMD. In contrast, chronic
MI hearts exhibited only very modest ventricular ectopy during the pacing
trains (33.3%, p<0.01 vs acute MI), but consistently exhibited ectopy after
a pause (91.6%), which was prevented by Ca2þ de-sensitization with blebbis-
tatin (10%, p<0.05). Compared to acute MI, the incidence of ventricular
tachycardia (VT) was significantly increased in chronic MI, which could
be prevented by blebbistatin (MI: 70%, MIþBleb: 10%, p<0.05, n=10 per
group).
Conclusion. Different patterns of arrhythmia induction are involved in acute
and chronic MI hearts. Our data suggest that increased myofilament Ca2þ sen-
sitivity strongly promotes ventricular ectopy and VT’s after a pause, but does
not affect ectopy during regular pacing.
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Rationale: Myocardial diastolic stiffness and cardiomyocyte passive force
(Fpassive) depend in part on titin isoform composition and phosphorylation.
Ca2þ/calmodulin-dependent protein kinase-IId (CaMKIId) phosphorylates
ion channels, Ca2þ-handling and myofilament proteins in the heart, but has
not been known to target titin.
Objective: To elucidate whether CaMKIId phosphorylates titin and regulates
Fpassive in normal and failing myocardium.
Methods and Results: Titin phosphorylation was assessed in CaMKIId/g
double-knockout (DKO) and transgenic CaMKIIdC-overexpressing (TG)
mouse hearts, as well as human hearts, by Pro-Q-Diamond/Sypro-Ruby
staining, autoradiography, and immunoblotting using phosphospecific titin
antibodies. CaMKII-dependent site-specific titin phosphorylation was quanti-
fied in vivo by mass spectrometry using SILAC mouse heart tissue mixed
with wildtype (WT) or DKO heart. Fpassive of single permeabilized cardio-
myocytes was recorded before and after CaMKII administration. Wedetected hypophosphorylation of all-titin in DKO and hyperphosphorylation
in TG compared to WT hearts. Conserved CaMKII-dependent phosphosites
were identified within titin’s PEVK-domain by quantitative mass spectrom-
etry and confirmed in recombinant human PEVK-fragments. CaMKII also
phosphorylated the cardiac titin N2B-unique sequence (N2Bus). Phosphory-
lation at specific PEVK/N2Bus sites was decreased in DKO and amplified in
TG versus WT hearts. Fpassive was elevated in DKO and reduced in TG com-
pared to WT cardiomyocytes. CaMKII-administration lowered Fpassive of WT
and DKO cardiomyocytes, an effect blunted by titin-phosphoantibody pre-
treatment. Human failing hypertrophic hearts revealed higher CaMKII ex-
pression/activity and phosphorylation at PEVK/N2Bus sites than nonfailing
donor hearts.
Conclusions: CaMKIId phosphorylates the titin springs at conserved serines/
threonines, thereby lowering Fpassive. Deranged CaMKIId-dependent titin
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Calmodulin (CaM) contains two structurally homologous domains that coop-
eratively bind to a range of different target proteins, such that upon binding
the opposing N- and C-domains wrap around the CaM-binding sequence. The
N-domain has a binding affinity (Kd = 24 mM) that is approximately 3-orders
of magnitude weaker than the C-domain (Kd = 11 nM) to the plasma mem-
brane Ca-ATPase (PMCA). These large differences in binding affinities facil-
itate ordered binding, which is necessary for the productive activation of
many target proteins. To better understand design principles that facilitate
molecular recognition, we have used directed evolution combined with
yeast surface display to identify mutations that enhance binding between
the N-domain of CaM and the PMCA, permitting the identification of com-
binatorial families of mutate N-domain proteins with nanomolar binding af-
finities (similar to that of the C-domain). All observed mutations occur at
noninterfacial sites that are naturally variable in Nature, suggesting that
hypervariable sites between different species may fine tune binding affinities.
Mutations in the N-domain that selectively destabilize the unbound state
commonly result in enhanced binding affinities with other CaM-binding se-
quences (i.e., skeletal myosin light chain kinase and ryanodine receptor). In
contrast, mutations that structurally couple with residues in the binding inter-
face result in selective high-affinity binding to the PMCA; these mutations
commonly result in decreased binding to other target proteins. In total, these
results indicate the value of using directed evolution approaches to identify
underlying principles that determine binding affinities.
This research was supported by the Defense Threat Reduction Agency
(DTRA).
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Achieving precise temporal control over signaling proteins is essential to the
understanding and reprogramming of cellular pathways. Direct regulation of
enzyme activity at the protein level can be gained by genetically-encoded
protein switches that offer the advantages of precision, specificity and minimal
invasiveness. The main challenge in engineering these switches lies in the de-
sign of an insertable, universal regulatory domain that can render any signaling
protein switchable. However, constructing such a domain is one of the most
challenging problems in protein design because of the necessity of engineering
and controlling multiple protein states. Here we present a rationally designed
domain, uniRapR, with a novel structure, that can be used as a universal,
insertable switch. UniRapR is natively disordered but robustly adapts a specific
conformation upon binding to the small molecule rapamycin. Insertion of
uniRapR into diverse kinases including Src, Lyn, FAK, and p38 enabled their
specific and temporally controlled activation in living cells. Switchable
